StockData
CONMED Corp logo

CONMED Corp (CNMD) stock

CNMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 14/3029% below fair value
$48.39−0.96 (-1.95%)

Close on Nov 17, 2026Market cap $1.44BP/E 20.0Yield 1.24%

Conmed price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Conmed's price to sales ratio was 1.1× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.7× to 4.7×, with a median of 1.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.1×+0.2
2025Dec 31, 20250.9×−0.7
2024Dec 31, 20241.7×−1.3
2023Dec 29, 20232.9×+0.3
2022Dec 30, 20222.7×−1.9
2021Dec 31, 20214.6×+0.8
2020Dec 31, 20203.8×+0.3
2019Dec 31, 20193.5×+1.3
2018Dec 31, 20182.2×+0.4
2017Dec 29, 20171.8×+0.2
2016Dec 30, 20161.6×−0.1
2015Dec 31, 20151.7×+0.0
2014Dec 31, 20141.7×+0.1
2013Dec 31, 20131.6×+0.5
2012Dec 31, 20121.1×+0.0
2011Dec 30, 20111.0×−0.1
2010Dec 31, 20101.1×–

More Conmed figures

See a number that looks wrong?